Stewart Frances, Rodie Vanessa A, Ramsay Jane E, Greer Ian A, Freeman Dilys J, Meyer Barbara J
Division of Developmental Medicine, University of Glasgow, Royal Infirmary, Glasgow, G31 2ER, UK.
Lipids. 2007 Apr;42(4):335-44. doi: 10.1007/s11745-006-3005-5. Epub 2007 Mar 27.
Transfer of fatty acids from mother to fetus during pregnancy is a requirement for optimal fetal growth. We report a longitudinal study of full maternal erythrocyte fatty acid profile assessed at each trimester of pregnancy [mean 12.5 (range 8-14), 26.1 (24-28) and 35.5 (33-38) weeks' gestation] and in the post partum period [18.1 (12-26) weeks]. The study recruited healthy women (n=47) from routine antenatal clinics at the Princess Royal Maternity Unit, Glasgow, Scotland. There were increases in 16:1n7 (22%, p=0.0005), 24:1n9 (13%, p=0.0032), 22:5n6 (25%, p=0.0003), 18:3n3 (41%, p=0.0007) and 22:6n3 (20%, p=0.0005) concentrations during pregnancy. The greatest increases took place between gestations at sampling of 12.5 and 26.1 weeks. The change in 16:1n7 concentration between gestations at sampling of 12.5 and 35.3 weeks was negatively associated with maternal booking body mass index (r=-0.40, p=0.006). The change in 22:6n3 concentration was correlated with the change in 24:1n9 (r=0.70, p<0.001). In samples taken four months post partum, 14:0 concentration was lower (29%, p=0.0002) and 24:0 concentration (15%, p=0.0009) and n6/n3 ratio (11%, p=0.0019) were higher than at a gestation at sampling of 12.5 weeks. In conclusion, several fatty acids are specifically mobilised during pregnancy. The correlation between maternal 22:6n3 and 24:1n9 suggests that mobilisation of these fatty acids may be coordinated. The inverse relationship between 16:1n7 and maternal central obesity warrants further investigation.
孕期母体向胎儿转运脂肪酸是胎儿最佳生长发育所必需的。我们报告了一项纵向研究,该研究评估了每位孕妇在妊娠各阶段[平均妊娠12.5周(范围8 - 14周)、26.1周(24 - 28周)和35.5周(33 - 38周)]以及产后阶段[18.1周(12 - 26周)]的全血红细胞脂肪酸谱。该研究从苏格兰格拉斯哥皇家公主妇产单元的常规产前诊所招募了健康女性(n = 47)。孕期16:1n7(升高22%,p = 0.0005)、24:1n9(升高13%,p = 0.0032)、22:5n6(升高25%,p = 0.0003)、18:3n3(升高41%,p = 0.0007)和22:6n3(升高20%,p = 0.0005)的浓度均有所增加。最大增幅发生在妊娠12.5周和26.1周的采样期之间。妊娠12.5周和35.3周采样期之间16:1n7浓度的变化与母体首次产检时的体重指数呈负相关(r = -0.40,p = 0.006)。22:6n3浓度的变化与24:1n9的变化相关(r = 0.70,p < 0.001)。在产后四个月采集的样本中,14:0浓度较低(降低29%,p = 0.0002),24:0浓度(升高15%,p = 0.0009)和n6/n3比值(升高11%,p = 0.0019)高于妊娠12.5周采样时。总之,孕期有几种脂肪酸会被特异性动员。母体22:6n3和24:1n9之间的相关性表明这些脂肪酸的动员可能是协同的。16:1n7与母体中心性肥胖之间的负相关关系值得进一步研究。